169 related articles for article (PubMed ID: 8300206)
1. Interleukin-1 is involved in mouse resistance to Mycobacterium avium.
Denis M; Ghadirian E
Infect Immun; 1994 Feb; 62(2):457-61. PubMed ID: 8300206
[TBL] [Abstract][Full Text] [Related]
2. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections.
Denis M; Ghadirian E
J Immunol; 1993 Nov; 151(10):5425-30. PubMed ID: 8228235
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response.
Petrofsky M; Bermudez LE
Clin Immunol; 1999 Jun; 91(3):354-8. PubMed ID: 10370382
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
Denis M
Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
[TBL] [Abstract][Full Text] [Related]
5. Mouse T cell clones against Mycobacterium avium: identification of clones that modify resistance against atypical mycobacteria infection.
Denis M
J Leukoc Biol; 1992 Jan; 51(1):7-12. PubMed ID: 1740647
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice from Mycobacterium avium infection by recombinant interleukin-12.
Kobayashi K; Kasama T; Yamazaki J; Hosaka M; Katsura T; Mochizuki T; Soejima K; Nakamura RM
Antimicrob Agents Chemother; 1995 Jun; 39(6):1369-71. PubMed ID: 7574533
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.
Wagner D; Sangari FJ; Kim S; Petrofsky M; Bermudez LE
J Leukoc Biol; 2002 Jan; 71(1):80-8. PubMed ID: 11781383
[TBL] [Abstract][Full Text] [Related]
8. In vivo modulation of atypical mycobacterial infection: adjuvant therapy increases resistance to Mycobacterium avium by enhancing macrophage effector functions.
Denis M
Cell Immunol; 1991 Apr; 134(1):42-53. PubMed ID: 2013106
[TBL] [Abstract][Full Text] [Related]
9. Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp. hominissuis in an experimental mouse infection.
Bruffaerts N; Vluggen C; Roupie V; Duytschaever L; Van den Poel C; Denoël J; Wattiez R; Letesson JJ; Fretin D; Rigouts L; Chapeira O; Mathys V; Saegerman C; Huygen K
PLoS One; 2017; 12(2):e0171895. PubMed ID: 28182785
[TBL] [Abstract][Full Text] [Related]
10. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.
Jeevan A; Yoshimura T; Foster G; McMurray DN
Infect Immun; 2002 Mar; 70(3):1245-53. PubMed ID: 11854207
[TBL] [Abstract][Full Text] [Related]
11. Role of CD40 ligand in Mycobacterium avium infection.
Hayashi T; Rao SP; Meylan PR; Kornbluth RS; Catanzaro A
Infect Immun; 1999 Jul; 67(7):3558-65. PubMed ID: 10377139
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis.
Feng CG; Kullberg MC; Jankovic D; Cheever AW; Caspar P; Coffman RL; Sher A
Infect Immun; 2002 Dec; 70(12):6672-9. PubMed ID: 12438341
[TBL] [Abstract][Full Text] [Related]
13. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species.
Roach DR; Martin E; Bean AG; Rennick DM; Briscoe H; Britton WJ
Scand J Immunol; 2001; 54(1-2):163-70. PubMed ID: 11439163
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Mycobacterium avium and human immunodeficiency virus type 1 (HIV-1) in bronchoalveolar macrophages of normal and HIV-1-infected subjects.
Denis M; Ghadirian E
Am J Respir Cell Mol Biol; 1994 Oct; 11(4):487-95. PubMed ID: 7917317
[TBL] [Abstract][Full Text] [Related]
15. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
Appelberg R; Sarmento AM
Clin Exp Immunol; 1990 Jun; 80(3):324-31. PubMed ID: 2115416
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy.
Kobayashi K; Yamazaki J; Kasama T; Katsura T; Kasahara K; Wolf SF; Shimamura T
J Infect Dis; 1996 Sep; 174(3):564-73. PubMed ID: 8769615
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta (TGF-b1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence.
Denis M; Ghadirian E
Microb Pathog; 1991 Nov; 11(5):367-72. PubMed ID: 1816490
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.
Appelberg R; Castro AG; Pedrosa J; Minóprio P
Immunology; 1994 Jul; 82(3):361-4. PubMed ID: 7959868
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice.
Castro AP; Aguas AP; Silva MT
Clin Exp Immunol; 1993 Jun; 92(3):466-72. PubMed ID: 8513578
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas.
Flórido M; Appelberg R
Immunology; 2006 May; 118(1):122-30. PubMed ID: 16630029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
